Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.
about
Natural compounds as anticancer agents: Experimental evidenceRole of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells.Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model.Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation.Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo.Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatmentRegulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK.Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo.Apoptosis signal-regulating kinase 1-thioredoxin complex dissociation by capsaicin causes pancreatic tumor growth suppression by inducing apoptosis.Mechanisms and therapeutic implications of cell death induction by indole compounds.Loss of MutL Disrupts Chk2-dependent Cell Cycle Control Through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.Actinobacillus pleuropneumoniae induces SJPL cell cycle arrest in G2/M-phase and inhibits porcine reproductive and respiratory syndrome virus replication.3,3'-Diindolylmethane alters Ca2+ homeostasis and viability in MG63 human osteosarcoma cells.3,3'-Diindolylmethane enhances apoptosis in docetaxel-treated breast cancer cells by generation of reactive oxygen species
P2860
Q26823107-00400269-5D45-403B-A21E-838C75B945C1Q33925357-EAD58784-B3A3-4029-88B0-E1B5A78294D6Q33997903-30C741E5-8868-4FBC-B7C3-941E8DCE4D61Q34142384-7F1DBC2A-4621-462A-809A-44065F5F38C6Q34405324-21646228-BFBE-441B-AE52-F3F3430139DCQ35164331-5F9CC214-6439-4CE1-BB52-835AE64B333DQ35847701-CE4C5A30-8E97-4699-A2EF-16E2A2DBBAD4Q35919027-0F3386FD-11EE-41DF-9A7F-7D394C13B424Q36050696-99135253-62C1-4B70-AEC0-F0B65781EB65Q36217167-45AD2FC1-6D2F-427A-9A46-F30FCA86BF93Q36218790-235A6D34-42FA-43FE-A759-1AB195E3F1ABQ37137367-BA6875B6-7832-4C4D-A835-9CFEB8DDC58AQ38628334-92290580-264F-466B-9611-11B52C983E2BQ38818857-C4E7D5D5-D965-4EE7-8005-D3FFBBAB76B3Q39458779-A583DDB1-8E40-4026-A870-9D4091EF2F37Q57279728-BF8FB492-3A36-471D-A54F-6141595ABF2E
P2860
Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@ast
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@en
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@nl
type
label
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@ast
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@en
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@nl
prefLabel
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@ast
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@en
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@nl
P2860
P356
P1476
Activation of checkpoint kinas ...... in human ovarian cancer cells.
@en
P2093
Prabodh K Kandala
Sanjay K Srivastava
P2860
P304
P356
10.1124/MOL.110.063750
P577
2010-05-05T00:00:00Z